Objective: Determine the contemporary incidence of pathogenic tracheal aspirate (TA) cultures when obtained within 12 h of birth, and to associate TA culture results with specific clinical conditions that increase the risk of infection.
Introduction
Infants with respiratory failure soon after delivery who require endotracheal intubation may have a tracheal aspirate (TA) sample collected for culture in the first hours of life to assist in the evaluation for pneumonia and sepsis. Such cultures are often obtained regardless of risk factors or clinical signs of infection in either the mother or infant. Evidence of the collection of early TA cultures was published in 1980 when Sherman reported data on 320 newborns, 25 (7.8%) of which showed bacteria on TA Gram's stain and bacterial growth on culture. 1 Then, in 1984, Sherman detailed 733 newborns correlating TA culture growth with bacteremia; 106 (14.5%) of these patients had TA culture growth. 2 Guidelines for routine perinatal screening and intrapartum antibiotic prophylaxis for Group B streptococcus (GBS) colonization were implemented in 1996, 3 decreasing the incidence of early-onset invasive GBS disease significantly. 4 In this study, we examined the contemporary incidence of TA culture growth when obtained within 12 h of birth. We hypothesized that the incidence of positive early TA cultures documented in earlier studies is greater than what is currently observed, due in part to the GBS prevention strategies now being used. We also examined the association between TA culture results and perinatal and neonatal risk factors, which increase the threat of infection. We sought to determine, on the basis of their present yield, whether the collection of early TA cultures is warranted on a routine basis, or should it be limited to certain clinical circumstances.
Methods
After institutional review board approval was obtained, a retrospective chart review was carried out on all infants admitted between August 2006 and January 2007 to a single outborn neonatal intensive care unit. During this 6-month time period, intubated patients had a TA sample sent at admission for Gram's stain and culture; however, TA sample collection was overlooked in some patients. No specimens were collected from non-intubated patients. We included only samples taken at <12 h after birth on the basis of the results of an earlier tracheal colonization study. 5 All data from the TA Gram's stain and culture report were recorded including cell type and quantity, bacterial growth and the hour of age at which the specimen was collected. Demographic data of the pertinent maternal conditions recorded included spontaneous rupture of membranes at <37 weeks gestation, duration of rupture of membranes, maternal perinatal fever, intravenous antibiotic administration before delivery, clinical chorioamnionitis, meconium stained amniotic fluid and GBS screening culture results. Birth weight, estimated gestational age, gender, delivery route, 1 and 5 min Apgar scores and antibiotic administration before sample collection were recorded from each infant's chart. Laboratory results recorded included the infant's initial blood culture and white blood cell count and differential. Absolute neutrophil count, absolute band count and band to total neutrophil ratio (I:T ratio) were calculated. Contamination of the TA culture was defined as growth of non-pathogenic bacteria or the growth of multiple species of a single potentially pathogenic bacterium. For analysis of the data, patients with cultures defined as contaminated were included with those patients having negative TA growth.
To determine the contemporary incidence of pathogenic TA culture growth, a total sample size of 340 patients was calculated on the basis of a 40% intubation rate, a 10% positive culture rate, an a of 0.05 and a 5% margin of error. Continuous data were analyzed using a two-tailed Student's t-test. Categorical data were analyzed using Fisher's exact test. A P-value of <0.05 was considered statistically significant.
Results
In total, 162 patients of 362 admissions were intubated within the first 12 h of life. A total of 139 of these patients had a TA specimen obtained before 12 h of life; 23 patients did not have a TA specimen obtained. No significant differences were noted between these two groups in birth weight, estimated gestational age, gender, route of delivery, Apgar scores or maternal risk factors (Table 1) . Bacterial growth was seen in 18 of the 139 TA specimens. Pathogenic bacteria from TA samples grew in nine patients ( Table 2) , establishing an incidence of 6.5%. The remaining nine TA cultures with bacterial growth were considered contaminated on the basis of the non-pathogenic nature of the bacteria obtained (bacillus, diphtheroids, Streptococcus sanguis, micrococcus, nonpathogenic neisseria, Streptococcus viridans) or the growth of multiple species (2-4 different species of coagulase-negative Staphylococcus). Each of these contaminated cultures showed only rare to light bacterial growth. No significant differences were seen in birth weight, estimated gestational age, gender, route of delivery and Apgar scores between those with a pathogenic and a negative TA culture. Gram's stain showed bacteria on four of the nine pathogenic TA cultures (Table 2) ; of the 130 patients with a negative TA culture, eight showed bacteria. The identification of bacteria on Gram's stain was significantly associated with a pathogenic TA culture (relative risk (RR) ¼ 8.5, P<0.005). White blood cells were found on six of the nine (67%) pathogenic specimen's Gram's stain (Table 2 ) and in 60 samples (46%) with negative TA culture growth. The presence of white blood cells had both low sensitivity (67%) and specificity (54%) for pathogen growth. The quantity of white blood cells seen on Gram's stain was noted as light, moderate or heavy. The detection of any white blood cells, from light to heavy, was not significantly associated with pathogenic culture growth (RR ¼ 2.2, P ¼ 0.31). Increasing quantities of white blood cells did not correlate with pathogenic culture growth either; the occurrence of moderate to heavy white blood cells on Gram's stain had a RR ¼ 1.7 (P ¼ 1.0) for pathogenic culture growth, whereas observing heavy white blood cells had a RR ¼ 4.2 (P ¼ 0.24).
Initial blood culture was positive in two of the nine patients (22%) who developed a pathogenic TA culture; the same organism was isolated from the two collection sites in each patient (Table 2) . No positive blood cultures were seen in patients with a negative TA culture. Infants with a pathogenic TA culture had lower white blood cell counts (7 500 vs 13 900 mm À3 , P<0.05) and a trend towards lower absolute neutrophil counts (2 600 vs 6 600 mm À3 , P ¼ 0.08) when compared with infants with a negative culture. An I:T ratio >0.2 was seen in 50% of the patients with a pathogenic TA culture, compared with 13% of those with a negative TA culture; this was significant for pathogenic TA culture growth (P ¼ 0.02). There was no difference in the absolute band count between the two groups.
Antibiotic administration to the mother, the infant before TA sample collection or both occurred in 104 of the 139 total cases, including eight of the nine patients with a pathogenic TA culture ( Table 2 ). The incidence of pathogenic TA culture growth was not affected by administration of antibiotics to the mother (8.0 vs 4.7%, P ¼ 0.51), to the infant before TA sample collection (5.0 vs 7.6%, P ¼ 0.73) or to either the mother or the infant (7.7 vs 2.9%,
Maternal fever (RR ¼ 7.7, P<0.04) and clinical chorioamnionitis (RR ¼ 6.4, P<0.02) were significantly associated with pathogenic TA culture results. No correlation was found between TA culture growth (pathogenic or contaminated) and the hour of age of sample collection. No other neonatal or maternal factors, including rupture of membranes more than 18 h before delivery or spontaneous rupture before 37 weeks gestation, were associated with pathogenic TA culture growth (Table 1) .
Discussion
Diagnosing respiratory infections in critically ill neonates is challenging. Current tools used in this assessment include chest radiographs, complete blood counts, blood cultures, TA cultures and clinical findings, all of which are often non-specific. Clinical decision-making regarding TA culture results can be especially difficult. The sample may be improperly collected or contaminated in the process of its collection, leading to inaccurate culture results. The trachea may be colonized with bacteria that are not causing infection, either from vaginal flora or after instrumentation for endotracheal tube placement, leading to false positive culture results. Earlier reports have shown a marked increase in the incidence of bacterial colonization if intubation occurs after 12 h of life. 5 In an attempt to limit the risk of confounding colonization, we defined early TA cultures as those obtained within 12 h of birth. Despite this restriction, half of all TA cultures, which grew bacteria were considered contaminated. In addition, some of the TA cultures classified as pathogenic here may in fact be false positives, with growth because of colonization or contamination, and not true infection. However, the pathogenic bacteria in this series can lead to significant morbidity and mortality if left untreated. Presented with a positive culture of one of these organisms, a clinician might be prudently compelled to provide specific treatment, even if there was a reasonable likelihood that the culture result was inaccurate. The pathogenic TA cultures in this series have additional evidence indicative of true infection, including suggestive history and physical findings along with laboratory results, to associate the culture findings with the clinical picture of pneumonia.
Evidence of inflammation helps validate the results of TA culture; therefore, measures of inflammation must be assessed both locally and systemically. The presence of white blood cells on Gram's stain would seem to provide local evidence; nevertheless, our data did not show a significant correlation with pathogenic culture growth. Proinflammatory cytokines have also been measured in tracheal fluid and serum as a marker for inflammation and infection, and as a risk factor for the development of bronchopulmonary dysplasia. [6] [7] [8] [9] However, these tests are not widely available or used frequently outside of research settings. Alterations in the white blood cell count and differential are often used as measures of systemic inflammation. Leukopenia was noted in patients with a pathogenic TA culture when compared with those with a negative culture, as was an I:T ratio greater than 0.2. Other serum markers of inflammation, such as C-reactive protein, could be used as well to corroborate culture results. C-reactive protein levels were not obtained in enough patients in this series to be evaluated adequately.
Pulmonary infiltrates on chest radiograph obtained from a neonate contribute to the diagnosis of pneumonia. A chest radiograph is also necessary to help exclude other potential causes of respiratory distress. In the immediate neonatal period though, infiltrates are often a non-specific sign, and are also noted with respiratory distress syndrome, retained lung fluid, pulmonary hemorrhage and heart failure. Lobar infiltrates would provide more specific evidence, but are uncommon in cases of neonatal pneumonia. In addition, infiltrates secondary to pneumonia may take several days to be seen on a chest film. These factors precluded the addition of radiography to the data analysis presented here.
Sampling of TA fluid provides the benefit of obtaining a second culture specimen, in addition to blood, to assess for neonatal infection. Antibiotic treatment can thereby be tailored to the specific organism and its sensitivities. It is easily and readily collected and preliminary results, in the form of a Gram's stain, can be available quickly. In this study, the administration of antibiotics before TA culture collection to either the mother or infant did not invalidate culture result; eight of the nine patients with pathogenic TA cultures had antibiotic pretreatment. Clinically, this finding is important as intrapartum antibiotic administration occurs regularly, and has increased with the adoption of GBS prophylaxis. The majority of the pathogenic TA cultures showed only rare or light bacterial growth. This could be a reflection of antibiotic pretreatment, which may lessen, but not eliminate, the bacterial load. The incidence of positive blood cultures (1.4%) may have been decreased by antibiotic treatment before sample collection. Antibiotic concentrations in the lung fluid are slower to rise when compared with the serum; therefore, pretreatment may affect TA culture to a lesser extent than blood culture.
Early-onset GBS infection has declined in the era of prenatal screening and intrapartum antibiotic prophylaxis; however, GBS remains a significant cause of morbidity and mortality in neonates. Despite the preventive steps in place and frequent antibiotic administration to the infant or mother before sample collection, four of the nine pathogenic TA cultures in this series were positive for GBS. One important concern arising from the institution of GBS prevention is an increase in the incidence of infection by non-GBS pathogens, including antibiotic resistant strains; 3 this was not encountered in the patients studied here. Escherichia coli and Haemophilus influenza, common organisms in neonatal infections, were identified in five of the nine pathogenic cultures with typical resistance patterns noted in these species.
Limitations to this retrospective study include the reliance on documentation in the medical record and the relatively small number of patients studied. A total of 23 patients (14%) did not have TA samples submitted for Gram's stain and culture. Demographically, this group was similar to the study population, but their exclusion may have altered the results. The study was powered to assess the contemporary incidence of pathogenic TA culture growth. Non-significant findings in some clinical scenarios may be secondary to inadequate study power in these areas.
This retrospective review of a single institution's experience with early TA cultures, collected within the first 12 h of life, is the only such report published since the institution of GBS prophylaxis measures in the mid-1990's. We calculated the contemporary incidence of pathogenic TA cultures, when obtained within the first 12 h of life, to be 6.5%. This is lower than the two earlier estimates of 7.8 and 14.5% published by Sherman in the early 1980's. Maternal factors of perinatal fever or clinical chorioamnionitis increased the risk of pathogenic TA culture growth significantly, whereas there was no correlation seen between TA culture and prolonged or premature rupture of membranes. The routine collection of TA fluid for culture in the first 12 h of life remains a useful modality for diagnosing neonates with bacterial respiratory infections.
